CEO SUMMARY: This fall, a parade of molecular and genetic test companies moved forward with initial public offerings (IPOs) of their stock. In September, Foundation Medicine raised $106 million from its IPO. Encouraged by this success, three different companies proceeded with IPOs during November. The IPOs of Veracyte and Oxford Immunotec raised $58 million and […]
Lab Companies’ IPOs Go Two-for-Three in November
It’s been a busy IPO season for companies with proprietary molecular and/or genetic tests
- By Robert Michel
- > From the Volume XX, No. 16 - December 2, 2013 Issue
- Tags: clinical lab, clinical lab test, clinical lab testing, Clinical Laboratory, clinical laboratory test, clinical laboratory testing, clinical trials, cpt, cpt code, cytopathology, diagnostic assays, fna, genetic test, genetic testing, genetic tests, lab test, lab testing, lab testing companies, laboratories, laboratory executive, laboratory organization, laboratory organizations, laboratory test, laboratory testing, Medicare, molecular assay, molecular diagnostic, molecular diagnostic assays, pathologists
